WuXi Biologics and Amicus Therapeutics have entered into an exclusive commercial manufacturing partnership for Amicus’ Pompe biologic ATB200. The initial contract is five years and will then be automatically renewed every two years until cancelled.   WuXi Biologics will be the exclusive commercial drug substance manufacturing partner and key commercial drug product supplier. WuXi Biologics will support Amicus with its “Global Dual Sourcing” strategy for the manufacture of bot...